A triple combination gemcitabine + romidepsin + cisplatin to effectively control triple-negative breast cancer tumor development, recurrence, and metastasis.
作者:
主题词
动物(Animals);抗肿瘤联合化疗方案(Antineoplastic Combined Chemotherapy Protocols);细胞系, 肿瘤(Cell Line, Tumor);细胞存活(Cell Survival);顺铂(Cisplatin);脱氧胞苷(Deoxycytidine);缩肽类(Depsipeptides);上皮-间质转化(Epithelial-Mesenchymal Transition);女(雌)性(Female);人类(Humans);小鼠(Mice);小鼠, 裸(Mice, Nude);肿瘤转移(Neoplasm Metastasis);肿瘤复发, 局部(Neoplasm Recurrence, Local);活性氧(Reactive Oxygen Species);信号传导(Signal Transduction);异种移植模型抗肿瘤试验(Xenograft Model Antitumor Assays)
DOI
10.1007/s00280-021-04298-y
PMID
34043046
发布时间
2022-12-07
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文